Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225136323> ?p ?o ?g. }
- W4225136323 endingPage "1775" @default.
- W4225136323 startingPage "1764" @default.
- W4225136323 abstract "Abstract There are limited comparison data throughout the dosing interval for generic versus brand metoprolol extended‐release (ER) tablets. We compared the pharmacokinetics (PKs) and pharmacodynamics of brand name versus two generic formulations (drugs 1 and 2) of metoprolol ER tablets with different time to maximum concentration ( T max ) in adults with hypertension. Participants were randomized to equal drug doses (50–150 mg/day) administered in one of two sequences (brand‐drug1‐brand‐drug2 or brand‐drug2‐brand‐drug1) and completed 24‐h PK, digital heart rate (HR), ambulatory blood pressure (BP), and HR studies after taking each formulation for greater than or equal to 7 days. Metoprolol concentrations were determined by liquid chromatography tandem mass spectrometry, with noncompartmental analysis performed to obtain PK parameters in Phoenix WinNonlin. Heart rate variability (HRV) low‐to‐high frequency ratio was determined per quartile over the 24‐h period. Thirty‐six participants completed studies with the brand name and at least one generic product. Among 30 participants on the 50 mg dose, the primary PK end points of area under the concentration‐time curve and C max were similar between products; T max was 6.1 ± 3.6 for the brand versus 3.5 ± 4.9 for drug 1 ( p = 0.019) and 9.6 ± 3.2 for drug 2 ( p < 0.001). Among all 36 participants, 24‐h BPs and HRs were similar between products. Mean 24‐h HRV low‐to‐high ratio was also similar for drug 1 (2.04 ± 1.35), drug 2 (1.86 ± 1.35), and brand (2.04 ± 1.77), but was more sustained over time for the brand versus drug 1 (drug × quartile interaction p = 0.017). Differences in T max between metoprolol ER products following repeated doses may have implications for drug effects on autonomic balance over the dosing interval." @default.
- W4225136323 created "2022-05-01" @default.
- W4225136323 creator A5000391786 @default.
- W4225136323 creator A5000476746 @default.
- W4225136323 creator A5008178617 @default.
- W4225136323 creator A5012683883 @default.
- W4225136323 creator A5013453267 @default.
- W4225136323 creator A5027176303 @default.
- W4225136323 creator A5027249949 @default.
- W4225136323 creator A5031712209 @default.
- W4225136323 creator A5037506185 @default.
- W4225136323 creator A5045797338 @default.
- W4225136323 creator A5050081552 @default.
- W4225136323 creator A5056166060 @default.
- W4225136323 creator A5061865147 @default.
- W4225136323 creator A5062673118 @default.
- W4225136323 creator A5062897128 @default.
- W4225136323 creator A5063440321 @default.
- W4225136323 creator A5066235983 @default.
- W4225136323 creator A5070710719 @default.
- W4225136323 creator A5072564819 @default.
- W4225136323 creator A5076056712 @default.
- W4225136323 creator A5088669682 @default.
- W4225136323 date "2022-05-21" @default.
- W4225136323 modified "2023-09-24" @default.
- W4225136323 title "A randomized, cross‐over trial of metoprolol succinate formulations to evaluate <scp>PK</scp> and <scp>PD</scp> end points for therapeutic equivalence" @default.
- W4225136323 cites W1574467103 @default.
- W4225136323 cites W1964007908 @default.
- W4225136323 cites W1965370746 @default.
- W4225136323 cites W1975912496 @default.
- W4225136323 cites W1979212156 @default.
- W4225136323 cites W1994157022 @default.
- W4225136323 cites W2012208367 @default.
- W4225136323 cites W2014476738 @default.
- W4225136323 cites W2023044098 @default.
- W4225136323 cites W2028960923 @default.
- W4225136323 cites W2029706261 @default.
- W4225136323 cites W2037359883 @default.
- W4225136323 cites W2042901826 @default.
- W4225136323 cites W2048604678 @default.
- W4225136323 cites W2061591133 @default.
- W4225136323 cites W2076778401 @default.
- W4225136323 cites W2082227074 @default.
- W4225136323 cites W2084860358 @default.
- W4225136323 cites W2089992214 @default.
- W4225136323 cites W2092981915 @default.
- W4225136323 cites W2093666415 @default.
- W4225136323 cites W2095233676 @default.
- W4225136323 cites W2098591026 @default.
- W4225136323 cites W2125109199 @default.
- W4225136323 cites W2133660688 @default.
- W4225136323 cites W2141163213 @default.
- W4225136323 cites W2142492119 @default.
- W4225136323 cites W2145912168 @default.
- W4225136323 cites W2150640566 @default.
- W4225136323 cites W2158424853 @default.
- W4225136323 cites W2164826114 @default.
- W4225136323 cites W2167854209 @default.
- W4225136323 cites W2172039055 @default.
- W4225136323 cites W2261584226 @default.
- W4225136323 cites W2285072859 @default.
- W4225136323 cites W2314262600 @default.
- W4225136323 cites W2759190050 @default.
- W4225136323 cites W2891423568 @default.
- W4225136323 cites W2899575621 @default.
- W4225136323 cites W2945177747 @default.
- W4225136323 cites W2945403424 @default.
- W4225136323 cites W2946721242 @default.
- W4225136323 cites W3005259661 @default.
- W4225136323 cites W3092661391 @default.
- W4225136323 cites W4225136323 @default.
- W4225136323 cites W4298441315 @default.
- W4225136323 cites W52877415 @default.
- W4225136323 doi "https://doi.org/10.1111/cts.13294" @default.
- W4225136323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35488487" @default.
- W4225136323 hasPublicationYear "2022" @default.
- W4225136323 type Work @default.
- W4225136323 citedByCount "1" @default.
- W4225136323 countsByYear W42251363232022 @default.
- W4225136323 crossrefType "journal-article" @default.
- W4225136323 hasAuthorship W4225136323A5000391786 @default.
- W4225136323 hasAuthorship W4225136323A5000476746 @default.
- W4225136323 hasAuthorship W4225136323A5008178617 @default.
- W4225136323 hasAuthorship W4225136323A5012683883 @default.
- W4225136323 hasAuthorship W4225136323A5013453267 @default.
- W4225136323 hasAuthorship W4225136323A5027176303 @default.
- W4225136323 hasAuthorship W4225136323A5027249949 @default.
- W4225136323 hasAuthorship W4225136323A5031712209 @default.
- W4225136323 hasAuthorship W4225136323A5037506185 @default.
- W4225136323 hasAuthorship W4225136323A5045797338 @default.
- W4225136323 hasAuthorship W4225136323A5050081552 @default.
- W4225136323 hasAuthorship W4225136323A5056166060 @default.
- W4225136323 hasAuthorship W4225136323A5061865147 @default.
- W4225136323 hasAuthorship W4225136323A5062673118 @default.
- W4225136323 hasAuthorship W4225136323A5062897128 @default.
- W4225136323 hasAuthorship W4225136323A5063440321 @default.
- W4225136323 hasAuthorship W4225136323A5066235983 @default.
- W4225136323 hasAuthorship W4225136323A5070710719 @default.